onkoview.com
  • Home
  • contact
  • ···
        • YouTube
    onkoview.com
    • Home
    • contact
    • ···
          • YouTube
      onkoview.com
      • Home
      • contact

      Layout H

      Clonal evolution of tumours

      Molecular action of p53 in carcinogenesis

      Molecular actions of the PML-RARα fusion protein in promyelocytic leukaemia

      The cell cycle – Part 1: Phases and checkpoints

      The cell cycle – Part 2: Cyclins, cyclin dependent kinases (CDKs), CDK inhibitors

      Apoptosis

      Oncogenic activation of receptor tyrosine kinases

      The EGF receptor tyrosine protein kinases

      The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors – Part 1: Inhibition of receptor activation via antibodies

      The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors – Part 2: Blocking of EGF receptor signaling via tyrosine kinase inhibitors

      BCR-ABL1 and the Philadelphia chromosome – Part 1: Normal and aberrant karyograms

      BCR-ABL1 and the Philadelphia chromosome – Part 2: The Philadelphia chromosome

      Layout H (with G as starter)

      Video
      Onkoview 2010

      Clonal evolution of tumours

      Video
      Onkoview 2010

      Molecular action of p53 in carcinogenesis

      Video
      Onkoview 2010

      Molecular actions of the PML-RARα fusion protein in promyelocytic leukaemia

      Video
      Onkoview 2010

      The cell cycle – Part 1: Phases and checkpoints

      The cell cycle – Part 2: Cyclins, cyclin dependent kinases (CDKs), CDK inhibitors

      Apoptosis

      Oncogenic activation of receptor tyrosine kinases

      The EGF receptor tyrosine protein kinases

      The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors – Part 1: Inhibition of receptor activation via antibodies

      The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors – Part 2: Blocking of EGF receptor signaling via tyrosine kinase inhibitors

      BCR-ABL1 and the Philadelphia chromosome – Part 1: Normal and aberrant karyograms

      BCR-ABL1 and the Philadelphia chromosome – Part 2: The Philadelphia chromosome

      Layout H (with load more button)

      Clonal evolution of tumours

      Molecular action of p53 in carcinogenesis

      Molecular actions of the PML-RARα fusion protein in promyelocytic leukaemia

      The cell cycle – Part 1: Phases and checkpoints

      The cell cycle – Part 2: Cyclins, cyclin dependent kinases (CDKs), CDK inhibitors

      Apoptosis

      Oncogenic activation of receptor tyrosine kinases

      The EGF receptor tyrosine protein kinases

      The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors – Part 1: Inhibition of receptor activation via antibodies

      The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors – Part 2: Blocking of EGF receptor signaling via tyrosine kinase inhibitors

      BCR-ABL1 and the Philadelphia chromosome – Part 1: Normal and aberrant karyograms

      BCR-ABL1 and the Philadelphia chromosome – Part 2: The Philadelphia chromosome

      Load More

      THE AUTHORS:
      Prof. Dr. med. Christoph Wagener
      Prof. Dr. med. Dr. rer nat. Oliver Müller
      VIDEO PRODUCTION:
      David Lengersdorf
      VOICEOVER :
      Ellen Wagner

      Youtube channel

      Most Viewed

      Clonal evolution of tumours

      382 views

      Molecular action of p53 in carcinogenesis

      471 views

      Molecular actions of the PML-RARα fusion protein in promyelocytic leukaemia

      523 views

      Copyright © 2025. Created by onkoview. Powered by artindustries. Privacy policy.